Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Maciej, Jabłkowski"'
Autor:
Anna Kasielska-Trojan, John T. Manning, Maciej Jabłkowski, Jolanta Białkowska-Warzecha, Oliwia Kwasniewska, Angelica L. Hirschberg, Bogusław Antoszewski
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
High right minus left (R-L) asymmetry of digit ratios has been reported to be linked to hospitalization for COVID-19. Here we examined the developmental patterns of this novel form of asymmetry in children and further explored their relationships to
Externí odkaz:
https://doaj.org/article/8b979c6c73394c078960524a211f2ea2
Autor:
Czarny, Sylwia Ziółkowska, Marcin Kosmalski, Łukasz Kołodziej, Aleksandra Jabłkowska, Janusz Zbigniew Szemraj, Tadeusz Pietras, Maciej Jabłkowski, Piotr Lech
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 14; Pages: 11307
Oxidative stress is one of the pillars crucial in the development of a non-alcoholic fatty liver disease (NAFLD) and may cause DNA damage. Since the main pathway responsible for the repair of oxidative DNA damage is the base-excision repair (BER) pat
Autor:
Maciej Jabłkowski, Radzisław Kordek, Piotr Czarny, Justyna Strycharz, Tomasz Sliwinski, Janusz Szemraj, Renata Krupa, Wojciech Malecki
Publikováno v:
Archives of Medical Science : AMS
IntroductionHepatocellular carcinoma (HCC) is very difficult to diagnose, especially in its early stages. Non-invasive diagnostic and prognostic factors for this cancer are urgently needed. The purpose of our study was to investigate whether the micr
Autor:
Maciej Jabłkowski, Joanna Woźny, Adam Rafał Poliwczak, Marzena Koziróg, Agnieszka Bała, Jolanta Białkowska
Publikováno v:
Archives of Medical Science : AMS
Introduction Cardiovascular diseases are ranked as the third cause of mortality among people infected with hepatitis C virus (HCV), but the relationship of infection with cardiovascular risk remains disputable. We have focused on the comprehensive us
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 11128, p 11128 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
One of the most common chronic liver disorders, affecting mainly people in Western countries, is nonalcoholic fatty liver disease (NAFLD). Unfortunately, its pathophysiological mechanism is not fully understood, and no dedicated treatment is availabl
Autor:
Janusz Szemraj, Joanna Wozny, Maciej Jabłkowski, Renata Krupa, Paulina Wigner, Tomasz Sliwinski, Piotr Czarny, Radzisław Kordek
Publikováno v:
DNA and Cell Biology. 36:693-708
The molecular mechanism of hepatocellular carcinoma (HCC) is related to DNA damage caused by oxidative stress products induced by hepatitis B virus (HBV) or C (HCV) infection and exposure to environmental pollutants. Single-nucleotide polymorphisms (
Autor:
Maciej Jabłkowski, John F. Flaherty, Maria Buti, Shuyuan Mo, Anuj Gaggar, Henry Lik-Yuen Chan, Fehmi Tabak, Jia-Horng Kao, Abhijit Chowdhury, Wan-Long Chuang, Elena Nurmukhametova, Young-Suk Lim, Audrey H. Lau, Scott Fung, Xiaoli Ma, Namiki Izumi, Edward Gane, Vithika Suri, Adrian Streinu-Cercel, Wai-Kay Seto
Publikováno v:
Clinical Hepatology.
Background TAF has shown efficacy non-inferior to that of TDF at Week 96 with less bone and renal effects. Following implementation of a protocol amendment to extend double-blind (DB) treatment for an additional year, 50% of patients were able to con
Autor:
Ewa Karpińska, Maciej Jabłkowski, Olga Tronina, Mariusz Łucejko, Krzysztof Simon, Iwona Mozer-Lisewska, Alicja Wiercińska-Drapało, Kornelia Karwowska, K. Rostkowska, Andrzej Horban, Robert Flisiak, Dorota Zarębska-Michaluk, Brygida Knysz, Anna Piekarska, Magdalena Tudrujek, Tadeusz Wojciech Łapiński, Arkadiusz Pisula, Jolanta Białkowska, Krzysztof Tomasiewicz, Waldemar Halota, Katarzyna Fleischer-Stępniewska, Wiesław Kryczka, Jerzy Jaroszewicz, Hanna Berak, Beata Bolewska, Marta Wawrzynowicz-Syczewska, Aleksander Garlicki, Ewa Janczewska, Grzegorz Madej, Khalil Nazzal
Publikováno v:
Clinical and Experimental Hepatology
Aim of the study This multicentre study aimed to examine the actual risk for drug-drug interactions in a cohort of Polish patients, and their impact on antiviral therapy. Material and methods Concomitant medications were analyzed in hepatitis C virus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a4fa378cddeb853f524c9768b172c5
https://ruj.uj.edu.pl/xmlui/handle/item/256155
https://ruj.uj.edu.pl/xmlui/handle/item/256155
Autor:
K. Simon, Andrzej Horban, Ewa Janczewska, Alicja Wiercińska-Drapało, Waldemar Halota, Khalil Nazzal, Robert Flisiak, Katarzyna Fleischer-Stępniewska, M. Lucejko, Kornelia Karwowska, Arkadiusz Pisula, Krzysztof Tomasiewicz, Anna Piekarska, Dorota Zarębska-Michaluk, Iwona Mozer-Lisewska, Hanna Berak, Brygida Knysz, Ewa Karpińska, K. Rostkowska, Maciej Jabłkowski, Olga Tronina, Jolanta Białkowska, Aleksander Garlicki, Grzegorz Madej, Magdalena Tudrujek, Marta Wawrzynowicz-Syczewska, Wiesław Kryczka, Jerzy Jaroszewicz, Beata Bolewska
Publikováno v:
Alimentary Pharmacology & Therapeutics. 44:946-956
SummaryBackground Virologic and safety outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin (OBV/PTV/r ± DSV ± RBV) therapy have shown high sustained virologic response (SVR) rates and good tolerability in most patient population
Autor:
Bogumiła Korcz-Ondrzejek, Anna Lachowicz-Wawrzyniak, Anna Strokowska, Iwona Mozer-Lisewska, Iwona Olszok, Wiesław Kryczka, Andrzej Horban, Maciej Jabłkowski, Anna Piekarska, Joanna Wernik, Rafał Krygier, Bronisława Szlauer, Joanna Musialik, Błażej Rozpłochowski, Robert Pleśniak, Barbara Baka-Ćwierz, Krzysztof Nowak, Jan Hałubiec, Włodzimierz Mazur, Dorota Zarębska-Michaluk, Barbara Sobala-Szczygieł, Krzysztof Simon, Agata Ruszala, Aleksander Garlicki, K. Witczak-Malinowska, Krzysztof Tomasiewicz, Jolanta Citko, Wojciech Chomczyk, Edyta Jezierska, Anna Boroń-Kaczmarska, Joanna Krzowska-Firych, Joanna Pogorzelska, Robert Flisiak, Witold Dobracki, Katarzyna Sikorska, Jacek Smykał, Marcin Kaczmarczyk, Beata Dobracka, Ewelina Tuchendler, Iwona Orłowska, Ewa Janczewska, Hanna Berak, Marek Matukiewicz, Waldemar Halota, Zbigniew Deroń, Grzegorz Madej, Jerzy Sieklucki, Arkadiusz Pisula, Barbara Postawa-Kłosińska
Publikováno v:
Clinical and Experimental Hepatology
The aim of the study Was to analyze the efficacy achieved with regimens available for chronic hepatitis C (CHC) in Poland between 2013 and 2016. Material and methods Data were collected from 29 centers and included 6786 patients with available sustai